Article info

Download PDFPDF
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
  1. Correspondence to Dr Walter Reinisch, Universitätsklinik für Innere Medizin III, Abteilung Gastroenterologie and Hepatologie, Waehringer Guertel 18-20, A-1090 Vienna, Austria; walter.reinisch{at}meduniwien.ac.at
View Full Text

Citation

Reinisch W, Sandborn WJ, Hommes DW, et al
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Publication history

  • Revised November 3, 2010
  • Accepted November 15, 2010
  • First published January 5, 2011.
Online issue publication 
May 10, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.